Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Regeneron Pharmaceuticals Inc. $709.05-14.42-1.99% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback